{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:44:29Z","timestamp":1782819869435,"version":"3.54.5"},"reference-count":41,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFC2500500"],"award-info":[{"award-number":["2021YFC2500500"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"abstract":"<jats:p>Aim: To evaluate the achievement of metabolic risk factor targets and influencing factors in ACS patients with diabetes during the 12 months after discharge.\nMethods: We retrospectively analyzed data from the Chinese Cardiovascular Association database-iHeart Project. Patients who were hospitalized with a diagnosis of ACS between 2014 and 2021 and who had at least one measurement record of LDL-C, BP, or HbA1c within 12 months after discharge were included. We further stratified patients by diabetes status and analyzed the correlation between clinical characteristics, measurement strategy, and achievement of targets.\nResults: Diabetes was identified in 1,027 (27.5%) of the eligible patients. The proportions of patients with diabetes achieving targets of LDL-C, BP, and HbA1c levels were 42.4%, 61.5%, and 43.7%, respectively. However, combined achievement rate was significantly lower in patients with diabetes than patients without diabetes (16.6% vs. 26.6%). Patients with diabetes who underwent the first measurement within three months or had \u22653 measurements within 12 months were positively associated with achieving combined targets.\nConclusions: The achievement of multifactorial targets among patients with ACS is suboptimal, particularly among patients with concomitant diabetes. The optimal measurement strategy post-discharge is essential for improving the comprehensive management of metabolic risk factors in ACS patients.<\/jats:p>","DOI":"10.5334\/gh.1400","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:30:59Z","timestamp":1739770259000},"page":"14","source":"Crossref","is-referenced-by-count":0,"title":["Target Achievements of Low-Density Lipoprotein Cholesterol, Blood Pressure, and Glucose in Patients with Diabetes after Acute Coronary Syndrome: Findings from the Chinese Cardiovascular Association Database &amp;ndash; iHeart Project"],"prefix":"10.5334","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5726-0311","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3523-0573","authenticated-orcid":false,"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3195-5657","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-6884","authenticated-orcid":false,"given":"Jingfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-4398","authenticated-orcid":false,"given":"Yihui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-4257","authenticated-orcid":false,"given":"Xiaofan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3581-6953","authenticated-orcid":false,"given":"Shaofeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7179-6275","authenticated-orcid":false,"given":"Cuilian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-4426","authenticated-orcid":false,"given":"Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8109-1634","authenticated-orcid":false,"given":"Tingbo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-1134","authenticated-orcid":false,"given":"Hanbin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0496-7541","authenticated-orcid":false,"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-7851","authenticated-orcid":false,"given":"Zeqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-0335","authenticated-orcid":false,"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-1692","authenticated-orcid":false,"given":"Guohai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9976-848X","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"11","key":"key20250217103052_B1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41569-023-00884-0","article-title":"Global epidemiology of acute coronary syndromes","volume":"20","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"25","key":"key20250217103052_B2","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990\u20132022","volume":"82","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"key20250217103052_B3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/CIRCULATIONAHA.119.040683","article-title":"Coronary revascularization of patients with diabetes mellitus in the setting of acute coronary syndromes","volume":"140","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"key20250217103052_B4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2013.01.005","article-title":"Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome","volume":"165","year":"2013","journal-title":"Am Heart J"},{"issue":"5","key":"key20250217103052_B5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2018.10.084","article-title":"Modifiable risk factors in young adults with first myocardial infarction","volume":"73","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20250217103052_B6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12933-018-0793-x","article-title":"Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project","volume":"17","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"key20250217103052_B7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.diabres.2019.07.002","article-title":"Prevalence of pre-existing dysglycaemia among inpatients with acute coronary syndrome and associations with outcomes","volume":"154","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"key20250217103052_B8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S2213-8587(22)00043-2","article-title":"Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: A post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"10","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"38","key":"key20250217103052_B9","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"key20250217103052_B10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/CP9.0000000000000029","article-title":"Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)","volume":"7","year":"2022","journal-title":"Cardiology Plus"},{"issue":"39","key":"key20250217103052_B11","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","year":"2023","journal-title":"Eur Heart J"},{"key":"key20250217103052_B12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12933-016-0391-8","article-title":"Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: A German\/Austrian DPV-multicenter analysis","volume":"15","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"key20250217103052_B13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1741826710393993","article-title":"Comparable short-term prognosis in diabetic and non-diabetic patients with acute coronary syndrome after cardiac rehabilitation","volume":"19","year":"2012","journal-title":"Eur J Prev Cardiol"},{"issue":"38","key":"key20250217103052_B14","article-title":"Long-term changes in HbA1c according to blood glucose control status during the first 3 months after visiting a tertiary university hospital","volume":"37","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"14","key":"key20250217103052_B15","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/eurjpc\/zwac107","article-title":"Achievement of ESC\/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab","volume":"29","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"key20250217103052_B16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/eurjpc\/zwab050","article-title":"Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: The Troms\u00f8 Study 2015\u201316","volume":"29","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"key20250217103052_B17","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/CIRCULATIONAHA.120.046783","article-title":"Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings","volume":"142","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"key20250217103052_B18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacc.2020.07.033","article-title":"Low-density lipoprotein cholesterol and adverse cardiovascular events after percutaneous coronary intervention","volume":"76","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"key20250217103052_B19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"issue":"9786","key":"key20250217103052_B20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): A cluster-randomised trial","volume":"378","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"key20250217103052_B21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"J-DOIT3 Study Group. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): An open-label, randomised controlled trial","volume":"5","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"key20250217103052_B22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-8587(19)30349-3","article-title":"Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"key20250217103052_B23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2047487314547652","article-title":"Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry","volume":"22","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"16","key":"key20250217103052_B24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCULATIONAHA.122.063399","article-title":"Association between achieved low-density lipoprotein cholesterol levels and long-term cardiovascular and safety outcomes: An Analysis of FOURIER-OLE","volume":"147","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"key20250217103052_B25","article-title":"Effect of multifactorial treatment targets and relative importance of hemoglobin a1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular diseases in Chinese primary care patients with type 2 diabetes mellitus: A population-based retrospective cohort study","volume":"6","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key20250217103052_B26","article-title":"cardiovascular risk factor status in hospitalized patients with type 2 diabetes in China","volume":"12","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"key20250217103052_B27","article-title":"Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: A cross-sectional study","volume":"9","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"key20250217103052_B28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1532-5415.2002.50103.x","article-title":"Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: The Cardiovascular Health Study","volume":"50","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"key20250217103052_B29","article-title":"Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices","volume":"147","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"key20250217103052_B30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pcd.2020.08.008","article-title":"Association and relative importance of multiple risk factor control on cardiovascular disease, end-stage renal disease and mortality in people with type 2 diabetes: A population-based retrospective cohort study","volume":"15","year":"2021","journal-title":"Prim Care Diabetes"},{"issue":"13","key":"key20250217103052_B31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/2047487319871735","article-title":"The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study","volume":"27","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"key20250217103052_B32","article-title":"Inequalities in glycemic and multifactorial cardiovascular control of type 2 diabetes: The Heart Healthy Hoods study","volume":"9","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"key20250217103052_B33","first-page":"1","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","volume":"326","year":"2021","journal-title":"JAMA"},{"issue":"25","key":"key20250217103052_B34","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"key20250217103052_B35","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/j.amjmed.2019.04.002","article-title":"Association between lipid testing and statin adherence in the Veterans Affairs Health System","volume":"132","year":"2019","journal-title":"Am J Med"},{"issue":"5","key":"key20250217103052_B36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjmed.2021.11.011","article-title":"Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification","volume":"135","year":"2022","journal-title":"Am J Med"},{"issue":"6","key":"key20250217103052_B37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjcard.2019.12.030","article-title":"Impact of lipid monitoring on treatment intensification of cholesterol lowering therapies (from the Veterans Affairs Healthcare System)","volume":"125","year":"2020","journal-title":"Am J Cardiol"},{"issue":"4","key":"key20250217103052_B38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jacl.2022.05.003","article-title":"Adherence to lipid monitoring and its impact on treat intensification of LDL-C lowering therapies at an urban academic medical center","volume":"16","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"5","key":"key20250217103052_B39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00380-016-0910-2","article-title":"Impact of combined lipid lowering and blood pressure control on coronary plaque: Myocardial Ischemia Treated by Percutaneous Coronary Intervention and Plaque Regression by Lipid Lowering and Blood Pressure Controlling Assessed by Intravascular Ultrasonography (MILLION) study","volume":"32","year":"2017","journal-title":"Heart Vessels"},{"issue":"15","key":"key20250217103052_B40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial","volume":"329","year":"2023","journal-title":"JAMA"},{"issue":"38","key":"key20250217103052_B41","first-page":"3720","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes [published correction appears in Eur Heart J. 2024 Apr 1;45(13):1145. doi: 10.1093\/eurheartj\/ehad870.]","volume":"44","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1400\/1889","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1400\/1890","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1400\/1891","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1400\/1889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:48:19Z","timestamp":1782816499000},"score":1,"resource":{"primary":{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/view\/1400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,9]]}},"URL":"https:\/\/doi.org\/10.5334\/gh.1400","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}